merck pennsylvania - Search News

News

Merck, Delaware

Merck plans to move manufacturing of its biggest drug, Keytruda, to a new US factory and lab in Delaware

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market. Keytruda is currently made in Ireland and by contract manufacturers in the United States.

CBS News on MSN · 7h

Merck to invest $1 billion in U.S. drug manufacturing plant

Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing.

Reuters on MSN · 10h

Merck to invest $1 billion in new Delaware plant to boost US manufacturing

U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Donald Trump's tariffs. The new facility will produce biologic drugs and Keytruda,

Health And Pharma3h

Merck Expands U.S. Biologics Manufacturing with New Wilmington Facility for KEYTRUDA

Merck has launched construction of a $1 billion biologics facility in Wilmington, set to become the U.S. production hub for ...

WFMZ-TV6d

Revenue down, earnings pp at Merck

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, warned that they expected a decline in 2025. They were right. In the first quarter of 2025 ...

WDEL9h

Merck breaks ground at Chestnut Run

Officials with Merck Biopharmaceutical Company broke ground on a new, 470,000 square foot biologics center at the Chestnut ...

NJBIZ5h

Merck breaks ground on $1B biotech center in Delaware

Merck starts construction on a $1B biologics facility in Wilmington, Del., expected to create 500+ jobs and support Keytruda production.

5don MSN

Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump’s ...

Revenue down, earnings up at Merck

Selling, general and administrative expenses were $2.6 billion in the first quarter, Merck noted, an increase of 3% compared with the first quarter of 2024. The increase was primarily due to higher ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results